AU9395998A - Compositions and methods for the treatment of immune related diseases - Google Patents
Compositions and methods for the treatment of immune related diseasesInfo
- Publication number
- AU9395998A AU9395998A AU93959/98A AU9395998A AU9395998A AU 9395998 A AU9395998 A AU 9395998A AU 93959/98 A AU93959/98 A AU 93959/98A AU 9395998 A AU9395998 A AU 9395998A AU 9395998 A AU9395998 A AU 9395998A
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- treatment
- methods
- related diseases
- immune related
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G01N33/5758—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5911997P | 1997-09-17 | 1997-09-17 | |
| US60059119 | 1997-09-17 | ||
| US5926397P | 1997-09-18 | 1997-09-18 | |
| US60059263 | 1997-09-18 | ||
| US6355097P | 1997-10-28 | 1997-10-28 | |
| US60063550 | 1997-10-28 | ||
| US6518697P | 1997-11-12 | 1997-11-12 | |
| US60066770 | 1997-11-12 | ||
| US6636497P | 1997-11-21 | 1997-11-21 | |
| US60066364 | 1997-11-21 | ||
| US6677097P | 1997-11-24 | 1997-11-24 | |
| US60065186 | 1997-11-24 | ||
| US8802698P | 1998-06-04 | 1998-06-04 | |
| US60088026 | 1998-06-04 | ||
| PCT/US1998/019437 WO1999014241A2 (en) | 1997-09-17 | 1998-09-17 | Compositions and methods for the treatment of immune related diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU9395998A true AU9395998A (en) | 1999-04-05 |
Family
ID=27568153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU93959/98A Abandoned AU9395998A (en) | 1997-09-17 | 1998-09-17 | Compositions and methods for the treatment of immune related diseases |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU9395998A (en) |
| WO (1) | WO1999014241A2 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001019991A1 (en) * | 1999-09-15 | 2001-03-22 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US6951924B2 (en) | 1997-03-14 | 2005-10-04 | Human Genome Sciences, Inc. | Antibodies against secreted protein HTEBYII |
| US6878806B2 (en) | 1997-03-14 | 2005-04-12 | Human Genome Sciences, Inc. | Human secreted protein HTEEB42 |
| US7169906B2 (en) | 1997-09-17 | 2007-01-30 | Genentech, Inc. | PRO211 polypeptides |
| US20030044839A1 (en) | 1997-09-17 | 2003-03-06 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US6974689B1 (en) | 1997-09-18 | 2005-12-13 | Genentech, Inc. | Nucleic acid encoding PRO211 polypeptides |
| IL141551A0 (en) * | 1998-09-17 | 2002-03-10 | Genentech Inc | Compositions and methods for the treatment of immune related diseases |
| EP1878796A3 (en) * | 1999-11-30 | 2008-01-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US6828302B1 (en) | 1999-12-08 | 2004-12-07 | Xcyte Therapies, Inc. | Therapeutic uses of depsipeptides and congeners thereof |
| ATE353663T1 (en) | 1999-12-08 | 2007-03-15 | Cyclacel Pharmaceuticals Inc | USE OF DEPSIPEPTIDES AND THEIR ANALOGUES AS IMMUNOSUPPRESSANTS FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, ALLERGIES AND HYPERPROLIFERATIVE SKIN DISEASES |
| US20030153015A1 (en) | 2000-01-20 | 2003-08-14 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US20050069878A1 (en) * | 2001-06-15 | 2005-03-31 | Henry Yue | Proteins associated with cell growth, differentiation, and death |
| WO2003008541A2 (en) * | 2001-07-16 | 2003-01-30 | Eli Lilly And Company | Extracellular junctional adhesion molecules |
| CA2675409A1 (en) * | 2001-10-19 | 2003-05-01 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| EP1513864A4 (en) * | 2002-02-08 | 2006-04-05 | Curagen Corp | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001524814A (en) * | 1997-03-14 | 2001-12-04 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | 28 human secreted proteins |
| JP2002503955A (en) * | 1997-03-21 | 2002-02-05 | ジェネティックス・インスチチュート・インコーポレーテッド | Secreted proteins and polynucleotides encoding them |
-
1998
- 1998-09-17 AU AU93959/98A patent/AU9395998A/en not_active Abandoned
- 1998-09-17 WO PCT/US1998/019437 patent/WO1999014241A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999014241A3 (en) | 1999-06-10 |
| WO1999014241A2 (en) | 1999-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU698509B2 (en) | Compositions for the treatment of rheumatoid-based arthritic diseases | |
| AU7722600A (en) | Compositions and methods for the diagnosis and treatment of immune disorders | |
| AU2212299A (en) | Compositions and methods for the treatment of tumor | |
| HUP9902068A3 (en) | Methods and compositions for the diagnosis and treatment of cancer | |
| AU6974996A (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
| AU2124397A (en) | Compositions and methods for the treatment and diagnosis of cardiovascular disease | |
| AU2495200A (en) | Compositions and methods for the treatment of tumor | |
| AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200731A1 (en) | Compositions and methods for the treatment of tumor | |
| AUPO727097A0 (en) | Method of treatment of hepatoma and pharmaceutical compositions for use therein | |
| AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
| IL136110A0 (en) | Methods and compositions for the treatment of psoriasis | |
| AU1575697A (en) | Compositions and methods for the treatment and diagnosis of cancer | |
| AU5309600A (en) | Compositions and methods for the treatment and diagnosis of immune disorders | |
| AU9395998A (en) | Compositions and methods for the treatment of immune related diseases | |
| AU5605398A (en) | Novel methods and compositions for treatment of autoimmune diseases | |
| AU9016898A (en) | Methods and compositions for treatment of restenosis | |
| AU2821295A (en) | Compositions and methods for the treatment of tumors | |
| AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
| HUP9800829A3 (en) | Collagen-based methods and formulations for the treatment of immune system-mediated diseases | |
| AU6786898A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
| IL141551A0 (en) | Compositions and methods for the treatment of immune related diseases | |
| AU6786598A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
| AU5699396A (en) | Compositions for the treatment of skin conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |